Hanover - Delayed Quote EUR
Swedish Orphan Biovitrum AB (B6E.HA)
26.70
-0.04
(-0.15%)
At close: 5:25:13 PM GMT+2
Loading Chart for B6E.HA
- Previous Close
26.74 - Open
27.02 - Bid 26.66 x --
- Ask 26.92 x --
- Day's Range
26.70 - 27.02 - 52 Week Range
22.06 - 30.52 - Volume
0 - Avg. Volume
1 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Jul 16, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: B6E.HA
View MorePerformance Overview: B6E.HA
Trailing total returns as of 5/29/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .
YTD Return
B6E.HA
2.84%
OMX Stockholm 30 Index (^OMX)
1.09%
1-Year Return
B6E.HA
12.28%
OMX Stockholm 30 Index (^OMX)
2.84%
3-Year Return
B6E.HA
35.73%
OMX Stockholm 30 Index (^OMX)
21.96%
5-Year Return
B6E.HA
20.01%
OMX Stockholm 30 Index (^OMX)
54.02%
Compare To: B6E.HA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
26.70
-0.15%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
25.24
-1.33%
Mkt Cap EUR 4.603B
Industry Drug Manufacturers—Specialty & Generic
4.1000
-0.12%
Mkt Cap EUR 4.661B
Industry Drug Manufacturers—Specialty & Generic
4.8740
+0.08%
Mkt Cap EUR 4.671B
Industry Drug Manufacturers—Specialty & Generic
17.00
0.00%
Mkt Cap 3.441B
Industry Drug Manufacturers—Specialty & Generic
5,040.00
0.00%
Mkt Cap HUF 1.741T
Industry Drug Manufacturers—Specialty & Generic
Statistics: B6E.HA
View MoreValuation Measures
As of 5/28/2025
Market Cap
9.24B
Enterprise Value
10.44B
Trailing P/E
25.52
Forward P/E
20.79
PEG Ratio (5yr expected)
1.62
Price/Sales (ttm)
3.85
Price/Book (mrq)
2.57
Enterprise Value/Revenue
4.34
Enterprise Value/EBITDA
12.14
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--